Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2010
10/07/2010US20100256165 Large conductance calcium-activated k channel opener
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256156 Heterocyclic compound
10/07/2010US20100256149 Novel arylamino n-heteraryl compounds as mek inhibitors
10/07/2010US20100256147 Biaryl acetamide derivatives as modulators of the kinase cascade for the treatment of hearing loss, osteoporosis and cell proliferation disorders
10/07/2010US20100256146 Trisubstituted piperidines
10/07/2010US20100256144 Kallikrein 7 modulators
10/07/2010US20100256143 Pharmaceutical compounds
10/07/2010US20100256142 Synthesis of functionalized octahydro-isoquinolin-1-one-8- carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256140 Indol-3-yl-carbonyl-piperidin-benzoimidazol derivatives
10/07/2010US20100256137 Indazolamide derivatives
10/07/2010US20100256131 Carbonyl compounds
10/07/2010US20100256130 Morpholinyl and pyrrolidinyl analogs
10/07/2010US20100256127 Substituted isoxazoles
10/07/2010US20100256126 Piperidine derivatives as nk3 receptor antagonists
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256114 Amido Compounds And Their Use As Pharmaceuticals
10/07/2010US20100256113 Quinolone derivative
10/07/2010US20100256108 Indazole acrylic acid amide compound
10/07/2010US20100256097 Inhibitors of janus kinases
10/07/2010US20100256096 Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
10/07/2010US20100255988 Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole derivatives and 5,5-dimethyl-3-[(1H-pyrazol-4-ylmethyl)sulfinyl]-4,5-dihydroisoxazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulations
10/07/2010US20100255005 Gamma secretase modulators
10/07/2010US20100254916 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in compositions and use thereof
10/07/2010CA2757415A1 Autotaxin inhibitors
10/07/2010CA2757413A1 Heterocyclic compounds as autotaxin inhibitors
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2749218A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators
10/06/2010EP2235009A1 Synthesis of paliperidone
10/06/2010EP2235004A1 Indazolyl, benzimidazolyl, benzotriazolyl substituted indolmone derivatives as kinase inhibitors useful in the treatment of cancer
10/06/2010EP2234999A1 Heteroaryl derivatives as orexin receptor antagonists
10/06/2010EP2234977A1 Viral polymerase inhibitors
10/06/2010EP2234971A1 Process and intermediates for the synthesis of heterocyclic substituted piperazines with cxcr3 antagonist activity
10/06/2010EP2234966A2 Azetidine derivatives, their preparation and their application in therapy
10/06/2010EP2234964A1 Intermediate compounds for the preparation of meso-substituted cyanine, merocyanine and oxonole dyes
10/06/2010EP2234615A1 4-imidazolidinones as kv1.5 potassium channel inhibitors
10/06/2010EP1723144B1 Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/06/2010EP1268446B1 Method for producing asymmetrical 4,6-bis(aryloxy)pyrimidine derivatives
10/06/2010CN1665501B Novel compounds as opioid receptor modulators
10/06/2010CN101855215A Method for preparing 5-haloalkyl-4,5-dihydroisoxazole derivatives
10/06/2010CN101851235A Heterocyclic compound and light-emitting element, light-emitting device, lighting device, and electronic device using the same
10/06/2010CN101851232A Photochromic isoxazole thiophene hybrid-type perfluorinated cyclopentene compound as well as synthesis method and application thereof
10/06/2010CN101851216A Oxadiazole derivative, and electronic device, and lighting device using oxadiazole derivative
10/06/2010CN101851173A Inhibitors of histone deacetylase
10/06/2010CN101849953A Inflammatory cytokine release inhibitor
10/06/2010CN101323589B Preparation of novel compound and montelukast sodium
10/05/2010US7807842 Synthesis of tetracyclines and analogues thereof
10/05/2010US7807841 Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors
10/05/2010US7807833 Chemical intermediates for sulfiding under mild conditions forming ring compounds for use as marine alkaloids; connecting reaction of 4 components, transforming c22-tert-butyltriphenylsilyl to acety group, cyclization, hydroxy group to methanesulonyl group, reduction of amide, dehydration,Heck reaction
10/05/2010US7807829 a phosphoramidate derivative of aprepitant or glucamine salt of phosphoramidate derivative of aprepitant ; emesis; inflammatory diseases; substance P (neurokinin-1) receptor antagonist
10/05/2010US7807709 3,4-substituted pyrrolidines; renin inhibitors; cardiovascular disorders, kidney disorders, neurodegenerative diorders and other diseases related to renin; e.g. N-((3S*,4S*)-4-{[Cyclopropyl-(4-methyl-pentanoyl)-amino]-methyl}-pyrrolidin-3-ylmethyl)-N-isopropyl-4-methoxy-3-(3-methoxy-propoxy)-benzamide
10/05/2010US7807700 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
10/05/2010US7807697 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile
10/05/2010US7807696 Isoxazole and isothiazole compounds useful in the treatment of inflammation
10/05/2010US7807694 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections
10/05/2010US7807692 peroxisome proliferator activated receptor agonists useful in the treatment and control of hyperglycemia that is symptomatic of non-insulin dependent diabetes, as well as dyslipidemia, hyperlipidemia, hypercholesterolemia, hypertriglyceridemia and obesity that are often associated with type II diabetes
10/05/2010US7807690 such as 2-(3-aminopyridin-2-yl)-5-[(1-imino-2,3-dihydro-1H-isoindol-5-ylamino)-(8-methoxy-4H-benzo[1,3]dioxin-6-yl)methyl]-2,4-dihydro-1,2,4-triazol-3-one, having serine protease inhibiting activity, and particularly excellent inhibiting activity against blood-coagulation factor VIIa
10/05/2010US7807672 Compounds that are ERK inhibitors
10/05/2010US7807670 viricides used for for treating a human papillomavirus (HPV) viral infections, for inhibiting HPV DNA replication or for preventing prenatal transmission of HPV from mother to baby by administering to the mother prior to giving birth
10/05/2010CA2352679C Process for the preparation of 3-aryl-benzofuran-2-ones
09/2010
09/30/2010WO2010111572A1 Compounds as cannabinoid receptor ligands
09/30/2010WO2010111460A1 Inhibitors of nf-kb
09/30/2010WO2010110686A1 Pyrimidinyl and 1,3,5 triazinyl benzimidazoles and their use in cancer therapy
09/30/2010WO2010110685A2 Pyrimddinyl and 1,3,5-triazinyl benzimtoazole sulfonamides and their use in cancer therapy
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010109172A1 Mannich base tetraoxanes (mannoxanes) and phenol substituted analogues
09/30/2010WO2010108913A1 Fluorophore-containing compounds and their use in the detection of phosphorylated (poly)peptides
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108861A1 Process for the preparation of propionic acid derivatives
09/30/2010WO2010108733A1 Insecticidal compounds
09/30/2010WO2010108608A1 Substituted piperidines as par-1 antagonists
09/30/2010WO2010089510A3 Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof
09/30/2010WO2009127949A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
09/30/2010US20100249405 Organic Compounds
09/30/2010US20100249402 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition for preventing or treating osteporosis comprising the same
09/30/2010US20100249400 Novel dihydronaphthalene compound and use thereof
09/30/2010US20100249399 Amide derivative and pharmaceutical composition containing the same
09/30/2010US20100249198 (r)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
09/30/2010US20100249192 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/30/2010US20100249191 N-Methyl benzamide derivatives
09/30/2010US20100249190 Hepatitis C Virus Inhibitors
09/30/2010US20100249179 Farnesoid X Receptor Agonists
09/30/2010US20100249176 Heterocycle amide t-type calcium channel antagonists
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249132 Imidazole derivatives
09/30/2010US20100249131 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
09/30/2010US20100249129 Compounds as cannabinoid receptor ligands
09/30/2010US20100249127 Substituted indolo-pyridinone compounds
09/30/2010US20100249126 Pyrimidine derivatives used as pi-3-kinase inhibitors
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249117 Factor xa inhibitors
09/30/2010US20100249111 Multi-ring compounds and uses thereof
09/30/2010US20100249099 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
09/30/2010US20100249097 Novel substituted tetrahydronaphthalenes, process for the preparation thereof and the use thereof as medicaments
09/30/2010US20100249096 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/30/2010US20100249094 Compounds for the Treatment of Hepatitis C
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 647